gabapentin

Generic: gabapentin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 100 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-0949
Product ID 50090-0949_bf9abed3-bc5b-4606-831d-1ae78cdea91d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078787
Listing Expiration 2026-12-31
Marketing Start 2008-01-31

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500900949
Hyphenated Format 50090-0949

Supplemental Identifiers

RxCUI
310430
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA078787 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-0949-0)
  • 100 CAPSULE in 1 BOTTLE (50090-0949-1)
  • 90 CAPSULE in 1 BOTTLE (50090-0949-2)
source: ndc

Packages (3)

50090-0949-0 30 CAPSULE in 1 BOTTLE (50090-0949-0) 50090-0949-1 100 CAPSULE in 1 BOTTLE (50090-0949-1) 50090-0949-2 90 CAPSULE in 1 BOTTLE (50090-0949-2)

Ingredients (1)

gabapentin (100 mg/1)

Linked Drug Pages (1)

Gabapentin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "bf9abed3-bc5b-4606-831d-1ae78cdea91d", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430"], "spl_set_id": ["ecb798a0-377d-4712-bb82-ec9d7116962f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-0949-0)", "package_ndc": "50090-0949-0", "marketing_start_date": "20141128"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (50090-0949-1)", "package_ndc": "50090-0949-1", "marketing_start_date": "20141128"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (50090-0949-2)", "package_ndc": "50090-0949-2", "marketing_start_date": "20141128"}], "brand_name": "Gabapentin", "product_id": "50090-0949_bf9abed3-bc5b-4606-831d-1ae78cdea91d", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-0949", "generic_name": "Gabapentin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "100 mg/1"}], "application_number": "ANDA078787", "marketing_category": "ANDA", "marketing_start_date": "20080131", "listing_expiration_date": "20261231"}